In 2011 the CFIDS Association (now the Solve ME/CFS Initiative) engaged a “drug repositioning” company called Biovista to search through thousands of drugs to find a new approach to ME/CFS. Biovista’s algorithm identified “every known gene, pathway, disease, anatomical location, cell structure and other components of potential drugs, including why […]